2007•Chinese Journal of Laboratory DiagnosisRequires access

Radioimmunoimaging study using pretargeting system on ~(153)Sm labeled anti-C-erbB-2 monoclonal antibody in nude mice grafted with human breast carcinoma

Wenjia Wang

Open publisher page 0 citations

Abstract

Objective To study using pretargeting system on radioimmunoimaging of 153Sm labeled anti-C-erbB-2 monodonal antibody and normal mice IgG in nude mice with human breast carcinoma and provide the basis for clinical use .Methods Group I 3-step pretargeting injected into the tail vein with 7.4 MBg/0.1 ml labeled antibody.Group II and III injected directly into the tail vein with 7.4 MBg/0.1ml labeled antibody.SPECT were measured after 2、4、8、24 h interval of injecion.Percent injected dosage of every gram tissue(%ID/g)were measured after 4、8、24 h interval to death.Results The tumor blood ratio of groupI reached 6.53、8.11、9.25 at 2、4、8 hours respectively.Radioactivity concertratoin peaked at 8 h in tumor site.the tumor/blood ratio of groupI was higher than groupII and groupIII.(P0.05).Conclusion Pretargeting system on radioimmunoimaging improves the amounts of locatingon toumors and yields a specific enhancing effect and also improve image quality.

About this research paper

What this paper is about

Objective To study using pretargeting system on radioimmunoimaging of 153Sm labeled anti-C-erbB-2 monodonal antibody and normal mice IgG in nude mice with human breast carcinoma and provide the basis for clinical use .Methods Group I 3-step pretargeting injected into the tail vein with 7.4 MBg/0.1 ml labeled antibody.Group II and III injected directly into the tail vein with 7.4 MBg/0.1ml labeled antibody.SPECT were measured after 2、4、8、24 h interval of injecion.Percent injected dosage of every gram tissue(%ID/g)were measured after 4、8、24 h interval to death.Results The tumor blood ratio of groupI reached 6.53、8.11、9.25 at 2、4、8 hours respectively.Radioactivity concertratoin peaked at 8 h in tumor site.the tumor/blood ratio of groupI was higher than groupII and groupIII.(P0.05).Conclusion Pretargeting system on radioimmunoimaging improves the amounts of locatingon toumors and yields a specific enhancing effect and also improve image quality.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study using pretargeting system on radioimmunoimaging of 153Sm labeled anti-C-erbB-2 monodonal antibody and normal mice IgG in nude mice with human breast carcinoma and provide the basis for clinical use .Methods Group I 3-step pretargeting injected into the tail vein with 7.4 MBg/0.1 ml labeled antibody.Group II and III injected directly into the tail vein with 7.4 MBg/0.1ml labeled antibody.SPECT were measured after 2、4、8、24 h interval of injecion.Percent injected dosage of every gram tissue(%ID/g)were measured after 4、8、24 h interval to death.Results The tumor blood ratio of groupI reached 6.53、8.11、9.25 at 2、4、8 hours respectively.Radioactivity concertratoin peaked at 8 h in tumor site.the tumor/blood ratio of groupI was higher than groupII and groupIII.(P0.05).Conclusion Pretargeting system on radioimmunoimaging improves the amounts of locatingon toumors and yields a specific enhancing effect and also improve image quality.

Key concepts: Pretargeting, Tail vein, Monoclonal antibody, Antibody, Chemistry, Carcinoma, Pathology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Radioimmunoimaging study using pretargeting system on ~(153)Sm labeled anti-C-erbB-2 monoclonal antibody in nude mice grafted with human breast carcinoma — Research Paper | ScholarLens